Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00584714 · ClinicalTrials.gov registry record
Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent
A clinical trial, sponsored by Point Biomedical.
- Terminated
- Registry status
- 300
- Enrollment target
NCT00584714 is a clinical trial that was terminated before completion, run by Point Biomedical. The registered enrollment target is 300 participants.
The verdict
NCT00584714 was terminated before completion, sponsored by Point Biomedical.
- TERMINATED
- Registry status
- 300 participants
- Enrollment target
Study Summary
The purpose of this study is to collect longer term follow-up information concerning health and survival on selected patients who received PB127 for injectable suspension in the pivotal trial (127-014).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00584714
The ClinicalTrials.gov registry entry for NCT00584714 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Point Biomedical, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00584714 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00584714 about?
NCT00584714 is a clinical study titled "Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent". The purpose of this study is to collect longer term follow-up information concerning health and survival on selected patients who received PB127 for injectable suspension in the pivotal trial (127-014).
What is the current status of trial NCT00584714?
This trial is currently terminated. The enrollment target is 300 participants. The study started on 2007-10. Estimated completion is 2008-07.
Who is sponsoring clinical trial NCT00584714?
This trial is sponsored by Point Biomedical, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.